No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹136.65Prev. Close
₹136.06Turnover(Lac.)
₹5,980.48Day's High
₹137.59Day's Low
₹13052 Week's High
₹138.952 Week's Low
₹67.19Book Value
₹62.18Face Value
₹2Mkt Cap (₹ Cr.)
3,856.95P/E
26.37EPS
4.98Divi. Yield
0.7616 May 2025
12:00 AM
AGM
Announcement Date: 16 May, 2025
16 May 2025
12:00 AM
BookCloser
13 May 2026
12:00 AM
Board Meeting
Agenda : Audited Result
11 Feb 2026
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 17 Feb, 2026
27 Dec 2024
12:00 AM
Split
Minoxidil is widely used as a topical treatment for hereditary hair loss and remains one of the most commonly prescribed dermatology ingredients globally
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 58.71 | 58.71 | 58.71 | 58.71 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,628.7 | 1,552.62 | 1,447.84 | 1,331.56 |
Net Worth | 1,687.41 | 1,611.33 | 1,506.55 | 1,390.27 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,184.02 | 1,966.98 | 1,894.47 | 983.3 |
yoy growth (%) | 11.03 | 3.82 | 92.66 | 38.36 |
Raw materials | -1,570.51 | -1,102.84 | -1,065.01 | -695.28 |
As % of sales | 71.9 | 56.06 | 56.21 | 70.7 |
Employee costs | -141.3 | -115.55 | -97.2 | -56.1 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 236.77 | 571.39 | 533.24 | 31.3 |
Depreciation | -43.26 | -38.92 | -35.73 | -30.21 |
Tax paid | -57.18 | -126.83 | -171.95 | -3.6 |
Working capital | -112.32 | 268.04 | 207.28 | -4.75 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 11.03 | 3.82 | 92.66 | 38.36 |
Op profit growth | -56.69 | 3.12 | 362.95 | 21.29 |
EBIT growth | -57.54 | 4.15 | 479.37 | 29.94 |
Net profit growth | -62.73 | 23.04 | 1,204.29 | 493.14 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 2,319.06 | 2,079.21 | 2,132.79 | 2,217.11 | 2,184.02 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,319.06 | 2,079.21 | 2,132.79 | 2,217.11 | 2,184.02 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 21.38 | 22.41 | 30.07 | 25.61 | 32.04 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,844.3 | 147.48 | 4,42,677.3 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,797.5 | 67.78 | 1,80,457.58 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,537.8 | 68.47 | 1,53,684.69 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,418.2 | 30.96 | 1,14,562.27 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,319 | 34.19 | 1,10,095.43 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Varinder Gupta
Joint Managing Director
Vikas Gupta
Chairman & Independent Director
Rajender Mohan Malla
Independent Director
Harpal Singh
Company Sec. & Compli. Officer
Abhay Raj Singh
Director (Works)
Kushal Kumar Rana
Independent Director
SHARAD TYAGI
Executive Director
Abhiraj Gupta
Independent Director
Rajni Jha
Trident Complex,
Raikot Road Barnala,
Punjab - 148101
Tel: 91-01679-244701-07
Website: http://www.iolcp.com
Email: investor@iolcp.com; contact@iolcp.com
205/208,
Anarkali Market, Jhandewalan Extn,
New Delhi - 110055
Tel: 011 - 42541234 / 235
Website: www.alankit.com
Email: rta@alankit.com
Summary
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active PharmaceuticalIngredient (API) and specialty chemicals sectors. Its extensive expertise i...
Read More
Reports by IOL Chemicals & Pharmaceuticals Ltd
What is the IOL Chemicals & Pharmaceuticals Ltd share price today?
What is the Market Cap of IOL Chemicals & Pharmaceuticals Ltd?
What is the PE and PB ratio of IOL Chemicals & Pharmaceuticals Ltd?
What is the 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd?
What is the CAGR of IOL Chemicals & Pharmaceuticals Ltd?
What is the shareholding pattern of IOL Chemicals & Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
